Regeneron : REGN

All Regeneron Articles

246 Articles

Jon C. Ogg | Dec 20, 2016 at 10:05 AM EST

Key Analyst Upgrades and Downgrades for Tuesday: Alcoa, Arch Coal, Baidu, Ciena, JD.com, Vale and Many More

Companies receiving analyst upgrades, downgrades, initiations or other key notes on Tuesday morning include Alcoa, Arch Coal, Baidu, Ciena, JD.com…

Lee Jackson | Dec 19, 2016 at 8:35 AM EST

Merrill Lynch Out With 11 Top Stock Ideas for 2017

Here are, the 11 top stock picks from the analysts at Merrill Lynch for 2017. Most look well-suited for growth…

Lee Jackson | Nov 11, 2016 at 9:35 AM EST

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

With the Republicans now set to control both Congress and the White House, many on Wall Street feel that there…

Chris Lange | Nov 4, 2016 at 10:05 AM EDT

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Regeneron Pharmaceuticals reported mixed third-quarter financial results before the markets opened on Friday.

Chris Lange | Oct 13, 2016 at 9:05 AM EDT

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

Ocular Therapeutix and Regeneron are attempting to develop a sustained release formulation of aflibercept that is suitable for advancement into…

Lee Jackson | Sep 19, 2016 at 8:25 AM EDT

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

An RBC report noted that although headline issues such as the Federal Reserve and the election are increasing volatility, four…

Jon C. Ogg | Aug 29, 2016 at 10:10 AM EDT

8 Top Movers and Hot Stocks for Monday

Stocks overall were fractionally higher early on Monday, August 29, 2016. That makes the big percentages gainers and losers and…

Jon C. Ogg | Aug 5, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More

The top analyst upgrades, downgrades and initiations seen on Friday morning include FireEye, Occidental Petroleum, SeaWorld, Teva Pharmaceutical, Windstream and…

Lee Jackson | Aug 4, 2016 at 10:40 AM EDT

Merrill Lynch Says the Time to Put Money Into Biotech Is Now

Though these four large cap biotech stocks are cheap relative to the S&P 500, history says they won’t stay that…

Paul Ausick | Jun 22, 2016 at 4:04 PM EDT

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

June 22, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in…

Jon C. Ogg | Apr 20, 2016 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: ArcelorMittal, Boeing, Intel, Schlumberger, Yahoo, Vivint Solar, Johnson & Johnson and More

The top analyst upgrades, downgrades and initiations seen on Wednesday morning include ArcelorMittal, Boeing, Intel, Johnson & Johnson, Schlumberger, Yahoo…

Chris Lange | Apr 1, 2016 at 9:50 AM EDT

Regeneron Rises on Positive Top-Line Results

Regeneron Pharmaceuticals has announced that two Phase 3 studies evaluating investigational dupilumab in adult patients with inadequately controlled moderate-to-severe atopic…

Chris Lange | Mar 16, 2016 at 1:35 PM EDT

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol…

Chris Lange | Mar 11, 2016 at 12:05 PM EST

Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) scored a win in a late-stage trial for the treatment of rheumatoid arthritis (RA). The…

Jon C. Ogg | Feb 25, 2016 at 5:15 PM EST

Why Citi Sees Huge Upside in 4 Top Biotechs Now

Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four…

1 … 8 9 10 11 12 … 17

Regeneron : REGN

All Regeneron Articles

Key Analyst Upgrades and Downgrades for Tuesday: Alcoa, Arch Coal, Baidu, Ciena, JD.com, Vale and Many More

Merrill Lynch Out With 11 Top Stock Ideas for 2017

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

8 Top Movers and Hot Stocks for Monday

Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More

Merrill Lynch Says the Time to Put Money Into Biotech Is Now

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: ArcelorMittal, Boeing, Intel, Schlumberger, Yahoo, Vivint Solar, Johnson & Johnson and More

Regeneron Rises on Positive Top-Line Results

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial

Why Citi Sees Huge Upside in 4 Top Biotechs Now

A $1.1 Million Portfolio That Pays $5,800 a Month and Lets a 70-Year-Old Skip the 4 Percent Rule Entirely

Cem Karsan Warns The S&P 500 Lost 40% in Real Terms Over 14 Years – And It Could Happen Again

Here Are Friday’s Top Wall Street Analyst Research Calls: Airbnb, Broadcom, Chipotle Mexican Grill, CrowdStrike, Fiserv, Lululemon Athletica, NVIDIA, Tesla, Walmart, and More

A $1.1 Million Portfolio That Pays $5,800 a Month and Lets a 70-Year-Old Skip the 4 Percent Rule Entirely

At 56 With $940,000 Saved and a Stable Federal Job, the Math Tilts Toward Working Six More Years Than Most Calculators Suggest

A $1.1 Million Portfolio That Pays $5,800 a Month and Lets a 70-Year-Old Skip the 4 Percent Rule Entirely

Cem Karsan Warns The S&P 500 Lost 40% in Real Terms Over 14 Years – And It Could Happen Again

Regeneron : REGN

All Regeneron Articles

Key Analyst Upgrades and Downgrades for Tuesday: Alcoa, Arch Coal, Baidu, Ciena, JD.com, Vale and Many More

Merrill Lynch Out With 11 Top Stock Ideas for 2017

Top Biotech and Health Care Stocks Set to Run on Huge Republican Sweep

Regeneron Investors Cheer Q3 Earnings Beat, Eylea Growth

Why Ocular Therapeutix Is Winning Big With Its Regeneron Collaboration

RBC Says These 4 Top Biotechs Could Have Big Upside Potential

8 Top Movers and Hot Stocks for Monday

Top Analyst Upgrades and Downgrades: FireEye, Occidental Petroleum, SeaWorld, Teva Pharma, Windstream, Zynga and More

Merrill Lynch Says the Time to Put Money Into Biotech Is Now

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

Top Analyst Upgrades and Downgrades: ArcelorMittal, Boeing, Intel, Schlumberger, Yahoo, Vivint Solar, Johnson & Johnson and More

Regeneron Rises on Positive Top-Line Results

Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict

Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial

Why Citi Sees Huge Upside in 4 Top Biotechs Now

A $1.1 Million Portfolio That Pays $5,800 a Month and Lets a 70-Year-Old Skip the 4 Percent Rule Entirely

Cem Karsan Warns The S&P 500 Lost 40% in Real Terms Over 14 Years – And It Could Happen Again

Here Are Friday’s Top Wall Street Analyst Research Calls: Airbnb, Broadcom, Chipotle Mexican Grill, CrowdStrike, Fiserv, Lululemon Athletica, NVIDIA, Tesla, Walmart, and More

Featured Reads

A $1.1 Million Portfolio That Pays $5,800 a Month and Lets a 70-Year-Old Skip the 4 Percent Rule Entirely

At 56 With $940,000 Saved and a Stable Federal Job, the Math Tilts Toward Working Six More Years Than Most Calculators Suggest